Hideki Nakasone
Saitama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 233 publications
Differential impact of GVHD prophylaxis on CMV infection and survival outcomes after cord blood transplantation in the era of letermovir.
Journal: Transplantation and cellular therapy
Published: May 25, 2026
Comparison of post-transplant cyclophosphamide and low-dose anti-thymocyte globulin with dose-dependent effects in mismatched unrelated donor transplantation.
Journal: British journal of haematology
Published: May 14, 2026
Systemic corticosteroid-free beclomethasone dipropionate monotherapy for mild acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation.
Journal: Leukemia & lymphoma
Published: May 12, 2026
Response-adapted lenalidomide-dexamethasone (LenDex) intensification after CyBorD induction for transplant-eligible multiple myeloma: the PIANO study.
Journal: Blood research
Published: April 11, 2026
Serum thioredoxin at allogeneic haematopoietic stem cell transplantation predicts acute graft-versus-host disease.
Journal: British journal of haematology
Published: March 23, 2026
Mycophenolate mofetil-based graft-versus-host disease prophylaxis is associated with an increased risk of human herpesvirus 6B encephalitis after cord blood transplantation.
Journal: Bone marrow transplantation
Published: March 18, 2026
Bidirectional associations between bacteremia and cytomegalovirus infection after allogeneic hematopoietic cell transplantation: JSTCT Transplant Complications Working Group.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: March 16, 2026
Conditioning-adapted methotrexate in cord blood transplantation for high-risk acute myeloid leukemia: a nationwide Japanese cohort analysis.
Journal: Scientific reports
Published: March 16, 2026
Haploidentical transplantation versus umbilical cord blood transplantation in acute myeloid leukemia with measurable residual disease.
Journal: Cytotherapy
Published: March 09, 2026
The impact of female-to-male allogeneic hematopoietic cell transplantation on survival outcomes varies by recipient age.
Journal: Transplantation and cellular therapy
Published: February 19, 2026
Donor age as a dual-risk factor for donor safety and recipient survival in allogeneic haematopoietic stem cell transplantation.
Journal: British journal of haematology
Published: February 05, 2026
Management of an Allogeneic HSCT Recipient with an SICD during and after Total Body Irradiation.
Journal: Internal medicine (Tokyo, Japan)
Published: February 01, 2026
Last Updated: 09/26/2026